Detalles de la búsqueda
1.
Levonadifloxacin, a recently approved benzoquinolizine fluoroquinolone, exhibits potent in vitro activity against contemporary Staphylococcus aureus isolates and Bengal Bay clone isolates collected from a large Indian tertiary care hospital.
J Antimicrob Chemother
; 75(8): 2156-2159, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32361727
2.
Can fosfomycin be an alternative therapy for infections caused by E. coli harbouring dual resistance: NDM and four-amino acid insertion in PBP3?
JAC Antimicrob Resist
; 5(2): dlad016, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36880086
3.
Genomics and structural insight into the masking of gentamicin-resistance in clinical Burkholderia pseudomallei strain VB29710 from India.
Diagn Microbiol Infect Dis
; 105(3): 115878, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36529021
4.
In Vitro Activity of Two Cefepime-Based Novel Combinations, Cefepime/Taniborbactam and Cefepime/Zidebactam, against Carbapenemase-Expressing Enterobacterales Collected in India.
Microbiol Spectr
; : e0492522, 2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36847537
5.
Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence.
Future Sci OA
; 6(4): FSO461, 2020 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32257374
6.
Comparative evaluation of susceptibility testing methods for colistin and polymyxin B among clinical isolates of carbapenem- resistant Klebsiella pneumoniae and Acinetobacter baumannii.
J Infect Dev Ctries
; 12(6): 504-507, 2018 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31940304
Resultados
1 -
6
de 6
1
Próxima >
>>